The Ensign Group Inc (ENSG)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $10.99B
Last updated: Nov 17, 2026 at 11:05 AM ET
The Ensign Group Inc (ENSG) Stock Forecast
Analysts expect The Ensign Group (ENSG) to earn $7.98 per share in the fiscal year ending Dec 31, 2026, on revenue of $5.91B. Of 5 analysts, 4 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 4 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 80% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 20.0% |
| Buy | 3 | 60.0% |
| Hold | 1 | 20.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 5
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 9.9% and revenue estimates rise 12.7%.
- Fiscal year ending Dec 31, 2026
- $7.98
- EPS consensus, revenue $5.91B
- Fiscal year ending Dec 31, 2027
- $8.77
- EPS consensus, revenue $6.66B
- Next report
- Feb 2, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $7.98 | $7.97 to $8.00 | 5 | $5.91B | $5.90B to $5.92B | 5 |
| Dec 31, 2027 | $8.77 | $8.65 to $8.97 | 5 | $6.66B | $6.53B to $6.72B | 5 |
Quarterly Estimates
The EPS consensus falls from $2.22 for the quarter ending Dec 31, 2026 to $2.13 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $2.22 | $2.12 to $2.30 | 7 | $1.63B | $1.55B to $1.69B | 7 |
| Mar 31, 2027 | $2.13 | $2.07 to $2.19 | 3 | $1.62B | $1.60B to $1.63B | 3 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 10 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 4 | 0 |
| Fiscal year ending Dec 31, 2027 | 4 | 0 |
| Quarter ending Mar 31, 2027 | 2 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 2.2% from $7.81.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $7.98 | $7.83 | $7.81 | $7.81 | $7.81 | +2.2% |
| Fiscal year ending Dec 31, 2027 | $8.77 | $8.59 | $8.55 | $8.55 | $8.55 | +2.6% |
| Quarter ending Mar 31, 2027 | $2.13 | $2.10 | $2.10 | $2.11 | $2.11 | +1.2% |
Frequently Asked Questions About ENSG
What is the ENSG stock forecast?
Consensus analyst estimates put The Ensign Group's EPS at $7.98 for the fiscal year ending Dec 31, 2026, on revenue of $5.91B. The consensus rating from 5 analysts is Buy.
How do analysts rate ENSG stock?
Of 5 analysts covering The Ensign Group, 1 rates it Strong Buy, 3 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from ENSG next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $7.98, with estimates from $7.97 to $8.00 from 5 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $8.77, with estimates from $8.65 to $8.97 from 5 analysts.
What revenue do analysts expect from The Ensign Group next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $5.91B, with estimates from $5.90B to $5.92B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $6.66B, with estimates from $6.53B to $6.72B.
How many analysts cover ENSG?
5 analysts rate The Ensign Group stock, and 5 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
ENSG pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts